Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: April 29, 2024 Report Code: GDME1733EPD-ST

Select Item

Atherectomy Devices Pipeline Market Report Overview

Atherectomy is a minimally invasive procedure that removes plaque from vessels. Atherectomy is especially valuable in eliminating highly calcified plaque. Atherectomy procedures may be used for coronary and peripheral vessels to open a blockage and restore blood flow. The atherectomy may be combined with angioplasty and stenting. Coronary Atherectomy Devices and Lower Extremity Peripheral Atherectomy Devices are covered under this category. One unit refers to a single atherectomy system, without consoles or accessories.

The Atherectomy Devices pipeline market report provides key information and data related to extensive coverage of the Atherectomy Devices under development. The report provides review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates. The report also reviews major players involved in the pipeline product development.

Key Segments ·       Lower Extremity Peripheral Atherectomy Devices

·       Coronary Orbital Atherectomy

·       Coronary Rotational Atherectomy

·       Coronary Atherectomy Devices

·       Coronary Laser Atherectomy
Key Territories ·       The US

·       Europe

·       China

·       Israel
Key Regulatory Paths ·       510(K)

·       CE

·       NMPA

·       PMA
Leading Companies ·       Acotec Scientific Holdings Ltd

·       Advanced Catheter Therapies Inc

·       ArioMedica Ltd.

·       Avinger Inc

·       Boston Scientific Corp
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Atherectomy Devices Pipeline Market by Segments

A few of the key segments in the Atherectomy Devices pipeline market are Lower Extremity Peripheral Atherectomy Devices, Coronary Orbital Atherectomy, Coronary Rotational Atherectomy, Coronary Atherectomy Devices, and Coronary Laser Atherectomy. As of April 2024, Lower Extremity Peripheral Atherectomy Devices have the most pipeline products.

Atherectomy Devices Pipeline Market Analysis by Segments, 2024 (%)

Atherectomy Devices Pipeline Market Analysis by Segments, 2024 (%)

Buy Full Report for More Segment Insights into the Atherectomy Devices Pipeline Market

Download a Free Report Sample

Atherectomy Devices Pipeline Market Segmentation by Territories

The key territories in the Atherectomy Devices market are the US, Europe, China, and Israel. As of April 2024, the US has the highest number of pipeline products in the Atherectomy Devices market.

Atherectomy Devices Pipeline Market Analysis by Territories, 2023 (%)

Atherectomy Devices Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Atherectomy Devices Pipeline Market

Download a Free Report Sample

Atherectomy Devices Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the Atherectomy Devices pipeline market are 510(K), CE, NMPA, and PMA. As of October 2024, 510(K) is the most followed pathway for pipeline products in the market.

Atherectomy Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Atherectomy Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Atherectomy Devices Pipeline Market

Download a Free Report Sample

Atherectomy Devices Pipeline Market – Competitive Landscape

A few of the key companies in the Atherectomy Devices pipeline market are Acotec Scientific Holdings Ltd, Advanced Catheter Therapies Inc., ArioMedica Ltd., Avinger Inc., and Boston Scientific Corp among others.

Advanced Catheter Therapies Inc (ACT): Advanced Catheter Therapies Inc (ACT) is a medical device company that provides novel catheter technologies targeting vascular diseases such as inflammation, thrombosis, occlusions, and restenosis. The company is developing a device for restenosis and catheters for endovascular debulking. It offers product development services such as design, IP patent filing, animal testing, and others. ACT provides treatment options for vascular disease such as atherectomy, thrombectomy, balloon angioplasty, and various types of drug-eluting and non-eluting vascular stents.ACT is headquartered in Chattanooga, Tennessee, the US.

Atherectomy Devices Pipeline Market Analysis by Companies

Atherectomy Devices Pipeline Market Analysis by Companies

Buy the Full Report for More Company Insights into the Atherectomy Devices Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Atherectomy Devices Pipeline Market Segments Outlook (As of April 2024)

  • Lower Extremity Peripheral Atherectomy Devices
  • Coronary Orbital Atherectomy
  • Coronary Rotational Atherectomy
  • Coronary Atherectomy Devices
  • Coronary Laser Atherectomy
  • Others

Atherectomy Devices Pipeline Market Territories Outlook (As of April 2024)

  • The US
  • Europe
  • China
  • Israel

Atherectomy Devices Pipeline Market Regulatory Paths Outlook (As of April 2024)

  • 510(K)
  • CE
  • NMPA
  • PMA

Scope

  • Extensive coverage of the Atherectomy Devices under development.

  • The report reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.

  • The report reviews the major players involved in the development of Atherectomy Devices and lists all their pipeline projects.

  • The coverage of pipeline products is based on various stages of development ranging from Early Development to Approved / Issued stage.

  • The report provides key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to –

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with the potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of Atherectomy Devices under development.

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Acotec Scientific Holdings Ltd
Advanced Catheter Therapies Inc
ArioMedica Ltd.
Avinger Inc
Boston Scientific Corp
Cardiovascular Systems Inc
Catheter Precision Inc
Covidien Ltd
Eximo Medical Ltd
GlobeStar Therapeutics Corp
Johns Hopkins University
MicroPort CRM SA
Most Cardio LLC
OrbusNeich
Shanghai MicroPort Rhythm MedTech Co Ltd
Terumo Corp
Terumo Interventional Systems
Terumo Medical Corp
TransMed7 LLC

Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Atherectomy Devices Overview 8

3 Products under Development 9

3.1 Atherectomy Devices – Pipeline Products by Stage of Development 9

3.2 Atherectomy Devices – Pipeline Products by Segment 10

3.3 Atherectomy Devices – Pipeline Products by Territory 11

3.4 Atherectomy Devices – Pipeline Products by Regulatory Path 12

3.5 Atherectomy Devices – Pipeline Products by Estimated Approval Date 13

3.6 Atherectomy Devices – Ongoing Clinical Trials 14

4 Atherectomy Devices – Pipeline Products under Development by Companies 15

4.1 Atherectomy Devices Companies – Pipeline Products by Stage of Development 15

4.2 Atherectomy Devices – Pipeline Products by Stage of Development 16

5 Atherectomy Devices Companies and Product Overview 17

5.1 Acotec Scientific Holdings Ltd Company Overview 17

5.1.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Advanced Catheter Therapies Inc Company Overview 19

5.2.1 Advanced Catheter Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 ArioMedica Ltd. Company Overview 20

5.3.1 ArioMedica Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 Avinger Inc Company Overview 21

5.4.1 Avinger Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Boston Scientific Corp Company Overview 22

5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Cardiovascular Systems Inc Company Overview 24

5.6.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.7 Catheter Precision Inc Company Overview 28

5.7.1 Catheter Precision Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 Covidien Ltd Company Overview 31

5.8.1 Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Eximo Medical Ltd Company Overview 32

5.9.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.10 GlobeStar Therapeutics Corp Company Overview 34

5.10.1 GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 Johns Hopkins University Company Overview 35

5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 MicroPort CRM SA Company Overview 36

5.12.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 Most Cardio LLC Company Overview 37

5.13.1 Most Cardio LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 OrbusNeich Company Overview 39

5.14.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 Shanghai MicroPort Rhythm MedTech Co Ltd Company Overview 40

5.15.1 Shanghai MicroPort Rhythm MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.16 Terumo Corp Company Overview 43

5.16.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43

5.17 Terumo Interventional Systems Company Overview 44

5.17.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 44

5.18 Terumo Medical Corp Company Overview 45

5.18.1 Terumo Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 45

5.19 TransMed7 LLC Company Overview 48

5.19.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 48

6 Atherectomy Devices- Recent Developments 51

6.1 Jan 23, 2024: AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease 51

6.2 Oct 30, 2023: Cardio Flow Announces Appointment of Chief Operating Officer 52

6.3 Jun 22, 2023: Eximo Medical Receives Additional 510 (k) Clearance for AURYON Atherectomy System 52

6.4 Jun 20, 2023: Avinger Announces Presentations by Key Opinion Leaders at LINC 2023 53

6.5 Jun 07, 2023: Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System 54

6.6 Apr 28, 2023: Leading data on the treatment of In-Stent Restenosis with Pantheris presented at Charing Cross International Symposium 54

7 Appendix 56

7.1 Methodology 56

7.2 About GlobalData 59

7.3 Contact Us 59

7.4 Disclaimer 59

Table

Atherectomy Devices – Pipeline Products by Stage of Development 9

Atherectomy Devices – Pipeline Products by Segment 10

Atherectomy Devices – Pipeline Products by Territory 11

Atherectomy Devices – Pipeline Products by Regulatory Path 12

Atherectomy Devices – Pipeline Products by Estimated Approval Date 13

Atherectomy Devices – Ongoing Clinical Trials 14

Atherectomy Devices Companies – Pipeline Products by Stage of Development 15

Atherectomy Devices – Pipeline Products by Stage of Development 16

Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

Coronary Rotational Atherectomy Device – Product Status 17

Coronary Rotational Atherectomy Device – Product Description 17

Peripheral Rotational Atherectomy Device – Product Status 18

Peripheral Rotational Atherectomy Device – Product Description 18

Advanced Catheter Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Atherectomy Device – Product Status 19

Atherectomy Device – Product Description 19

ArioMedica Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20

Atherectomy Device – Product Status 20

Atherectomy Device – Product Description 20

Avinger Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Wolverine Catheter – Product Status 21

Wolverine Catheter – Product Description 21

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22

Peripheral Atherectomy Device – Product Status 22

Peripheral Atherectomy Device – Product Description 22

Rota Tesla Atherectomy System – Product Status 23

Rota Tesla Atherectomy System – Product Description 23

Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Fourth Generation Diamondback 360 Orbital Atherectomy System – Product Status 24

Fourth Generation Diamondback 360 Orbital Atherectomy System – Product Description 24

Laser Atherectomy Device – Product Status 25

Laser Atherectomy Device – Product Description 25

Mixed Plaque Atherectomy System – Product Status 25

Mixed Plaque Atherectomy System – Product Description 25

Next Gen OAS System – Coronary – Product Status 26

Next Gen OAS System – Coronary – Product Description 26

Third Generation Diamondback 360 Orbital Atherectomy System – Product Status 26

Third Generation Diamondback 360 Orbital Atherectomy System – Product Description 27

Catheter Precision Inc Pipeline Products & Ongoing Clinical Trials Overview 28

DABRA – Coronary Artery Disease – Product Status 28

DABRA – Coronary Artery Disease – Product Description 28

DABRA – In-Stent Restenosis – Product Status 29

DABRA – In-Stent Restenosis – Product Description 29

DABRA Catheter – Lithotripsy – Product Status 29

DABRA Catheter – Lithotripsy – Product Description 30

Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Gen II SilverHawk – Product Status 31

Gen II SilverHawk – Product Description 31

Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

AURYON Atherectomy System – CAD – Product Status 32

AURYON Atherectomy System – CAD – Product Description 32

AURYON Atherectomy System – Venous Disease – Product Status 33

AURYON Atherectomy System – Venous Disease – Product Description 33

GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 34

Atherectomy Catheter II – Product Status 34

Atherectomy Catheter II – Product Description 34

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 35

Oscillatory Atherectomy Device – Product Status 35

Oscillatory Atherectomy Device – Product Description 35

MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview 36

Coronary Rotational Atherectomy Catheter – Product Status 36

Coronary Rotational Atherectomy Catheter – Product Description 36

Most Cardio LLC Pipeline Products & Ongoing Clinical Trials Overview 37

Atherectomy Catheter – Product Status 37

Atherectomy Catheter – Product Description 37

Extractor Wire – Product Status 38

Extractor Wire – Product Description 38

Micro-Emulsifier – Product Status 38

Micro-Emulsifier – Product Description 38

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 39

Large Vessel ATK Mixed Plaque – Product Status 39

Large Vessel ATK Mixed Plaque – Product Description 39

Shanghai MicroPort Rhythm MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Coronary Atherectomy System – Product Status 40

Coronary Atherectomy System – Product Description 40

Shanghai MicroPort Rhythm MedTech Co Ltd – Ongoing Clinical Trials Overview 41

Coronary Atherectomy System – A Prospective, Multicenter Clinical Trial of Coronary Atherectomy System in Patients With Calcified Coronary Artery Lesion 42

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43

Kenma – Product Status 43

Kenma – Product Description 43

Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 44

Atherectomy Device – Product Status 44

Atherectomy Device – Product Description 44

Terumo Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 45

Kaitoh Atherectomy System – Product Status 45

Kaitoh Atherectomy System – Product Description 45

Terumo Medical Corp – Ongoing Clinical Trials Overview 46

Kaitoh Atherectomy System – Kaitoh Atherectomy System: Peripheral Artery Revascularization of Stenotic/Restenotic Disease Using the Atherectomy System in the Peripheral Arteries 47

TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 48

Corsair Atherectomy Device – Product Status 48

Corsair Atherectomy Device – Product Description 48

Corsair II – Product Status 49

Corsair II – Product Description 49

Mustang – Product Status 49

Mustang – Product Description 50

Glossary 58

Figures

Atherectomy Devices – Pipeline Products by Stage of Development 9

Atherectomy Devices – Pipeline Products by Segment 10

Atherectomy Devices – Pipeline Products by Territory 11

Atherectomy Devices – Pipeline Products by Regulatory Path 12

Atherectomy Devices – Pipeline Products by Estimated Approval Date 13

Atherectomy Devices – Ongoing Clinical Trials 14

Frequently asked questions

Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Atherectomy Devices reports
Medical Devices
New
Transcatheter Pulmonary Valve Replacement (TPVR) Market Size by Segments, Share,…
$7,500 | April 2026
Medical Devices
New
Intravascular Ultrasound System (IVUS) Consoles Market Size by Segments, Share,…
$7,500 | April 2026
Medical Devices
New
Dialysis Machines Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | April 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more